LPL Financial’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-129,608
Closed -$814K 6317
2026
Q1
$814K Buy
129,608
+102,910
+385% +$956K ﹤0.01% 4358
2025
Q4
$327K Sell
26,698
-1,677
-6% -$27.4K ﹤0.01% 5080
2025
Q3
$582K Buy
28,375
+1,985
+8% +$31.5K ﹤0.01% 4494
2025
Q2
$356K Buy
+26,390
New +$289K ﹤0.01% 4647
2022
Q1
Sell
-6,653
Closed -$413K 4337
2021
Q4
$413K Buy
6,653
+3,570
+116% +$271K ﹤0.01% 3435
2021
Q3
$264K Sell
3,083
-220
-7% -$13.8K ﹤0.01% 3751
2021
Q2
$204K Buy
+3,303
New +$168K ﹤0.01% 3891

Other funds holding OPRX

LPL Financial's OPRX Position: Q2 2026 in Review

LPL Financial sold out of OptimizeRx (OPRX) in Q2 2026, closing a stake of 129,608 shares — an estimated $814K sold.

LPL Financial first reported a position in OPRX in Q2 2021 and held it in 7 quarters. The position peaked at $814K in Q1 2026. 113 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

  • LPL Financial reported no remaining OptimizeRx position as of Q2 2026 after selling out during the quarter.
  • LPL Financial sold 129,608 OptimizeRx shares in Q2 2026, an estimated $814K.
  • LPL Financial first reported a position in OptimizeRx in Q2 2021 and held it in 7 quarters.
  • LPL Financial's OptimizeRx position peaked at $814K in Q1 2026.
  • 113 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.